Press Releases
Stanza demonstrated significant improvements compared to an active control on virtually all endpoints, including fibromyalgia-related well-being, pain intensity, pain interference,…
Read this Article >
Press Releases
SAN FRANCISCO–Swing Therapeutics, a leading developer of digital therapies for chronic pain conditions, today announced the successful completion of and…
Read this Article >
Press Releases
Today marks an important milestone at Swing Therapeutics: Stanza, the first prescription digital therapy for fibromyalgia patients, is now commercially…
Read this Article >
Press Releases
Swing Therapeutics, a digital therapeutics company developing evidence-backed treatments for autoimmune and chronic pain conditions, today announced that it has…
Read this Article >
Press Releases
Swing Therapeutics announced today that the FDA has granted Breakthrough Device Designation to the company’s digital therapeutic for the management…
Read this Article >
Recent Comments